Operator of drug discovery platform intended to develop novel FDA-approved psychoactive medicines. The company's platform leverages plant derived compounds to accelerate the development of novel therapeutics, enabling physicians with the treatment and prevention of psychiatric and neurological disorders.
Currently, there are no issues on this topic.